《大行報告》花旗:理想汽車(LI.US)上季淨利潤高於預期 首季指引強勁
花旗發表報告指,理想汽車(LI.US)去年第四季純利按年下跌10%至2.65億元人民幣,但表現優於市場預期的錄得虧損。按非通用會計準則計(non-GAAP),集團季度純利為9.68億元人民幣,按年增長41%,同樣好過市場預期的2億元至3億元人民幣。盈利表現勝預期主要由於良好控制研發、銷售與一般及行政開支。
另一方面,集團設定今年首季的交付目標為5.2萬至5.5萬架,按年上升64%至73.4%,亦優於市場預期的不足5萬架。至於首季總收入指引為174.5億元至184.5億元人民幣,按年增長82.5%至93%。
花旗維持對理想汽車美股「買入」評級,目標價51.5美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.